Circumferential resection margin rates in esophageal cancer resection: oncological equivalency and comparable clinical outcomes between open versus minimally invasive techniques - a retrospective cohort study

被引:0
|
作者
Patel, Pranav H. [1 ]
Patel, Nikhil M. [1 ]
Doyle, Joseph P. [1 ]
Patel, Hina K. [1 ]
Alhasan, Yousef [1 ]
Luangsomboon, Alfa [1 ]
Petrou, Nikoletta [1 ]
Bhogal, Ricky H. [1 ,2 ]
Kumar, Sacheen [1 ,2 ,3 ]
Chaudry, Mohammed A. [1 ]
Allum, William H. [1 ]
机构
[1] Royal Marsden Hosp NHS Fdn Trust, Dept Upper GI Acad Surg, London SW1X 7HY, England
[2] Inst Canc Res, Upper Gastrointestinal Surg Oncol Res Grp, London SW1X 7HY, England
[3] Cleveland Clin London Hosp, Digest Dis & Surg Inst, Dept Upper GI Surg, London SW1X 7HY, England
关键词
esophageal cancer; cancer resection margin; esophagectomy; esophago-gastrectomy; laparoscopic surgery; surgical oncology; GASTROESOPHAGEAL JUNCTION; ESOPHAGOGASTRIC JUNCTION; OPEN-LABEL; PLUS CHEMOTHERAPY; ADENOCARCINOMA; INVOLVEMENT; SURVIVAL; CHEMORADIOTHERAPY; CLASSIFICATION; CAPECITABINE;
D O I
10.1097/JS9.0000000000001296
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background:Radical surgery for esophageal cancer requires macroscopic and microscopic clearance of all malignant tissue. A critical element of the procedure is achieving a negative circumferential margin (CRM) to minimize local recurrence. The utility of minimally invasive surgery poses challenges in replicating techniques developed in open surgery, particularly for hiatal dissection in esophago-gastrectomy. In this study, the technical approach and clinical and oncological outcomes for open and laparoscopic esophago-gastrectomy are described with particular reference to CRM involvement.Materials and methods:This cohort study included all patients undergoing either open or laparoscopic esophago-gastrectomy between January 2004 and June 2022 in a single tertiary center. A standard surgical technique for hiatal dissection of the esophago-gastric junction developed in open surgery was adapted for a laparoscopic approach. Clinical parameters, length of stay (LOS), postoperative complications, and mortality data were collected and analyzed by a Mann-Whitney U or Fisher's exact method.Results:Overall 447 patients underwent an esophago-gastrectomy in the study with 219 open and 228 laparoscopic procedures. The CRM involvement was 18.8% in open surgery and 13.6% in laparoscopic surgery. The 90-day-mortality for open surgery was 4.1 compared with 2.2% for laparoscopic procedures. Median Intensive care unit (ITU), inpatient LOS and 30-day readmission rates were shorter for laparoscopic compared with open esophago-gastrectomy (ITU: 5 versus 8 days, P=0.0004; LOS: 14 versus 20 days, P=0.022; 30-day re-admission 7.46 versus 10.50%). Postoperative complication rates were comparable across both cohorts. The rates of starting adjuvant chemotherapy were 51.8 after open and 74.4% in laparoscopic esophago-gastrectomy.Conclusion:This study presents a standardized surgical approach to hiatal dissection for esophageal cancer. The authors present equivalence between open and laparoscopic esophago-gastrectomy in clinical, oncological, and survival outcomes with similar rates of CRM involvement. The authors also observe a significantly shorter hospital length of stay with the minimally invasive approach.
引用
收藏
页码:6257 / 6267
页数:11
相关论文
共 42 条
  • [41] Long-term and short-term outcomes of laparoscopic versus open resection following tube decompression for obstructive colorectal cancer: a single-center retrospective study
    Kiyoaki Sugiura
    Yuki Seo
    Hikaru Aoki
    Yoshihiko Onishi
    Yusuke Nishi
    Norihiro Kishida
    Motomu Tanaka
    Yasuhiro Ito
    Hideyuki Tokura
    Takayuki Takahashi
    Surgery Today, 2022, 52 : 1284 - 1291
  • [42] The Clinical Outcomes of Thoracoscopic Versus Open Lobectomy for Non-Small-Cell Lung Cancer After Neoadjuvant Therapy: A Multi-Center Retrospective Cohort Study
    Cao, Jinlin
    Zhang, Chong
    Zhang, Xun
    Liu, Lunxu
    Li, Xiaofei
    He, Jianxing
    Xu, Lin
    Fu, Xiangning
    Liu, Yang
    Liu, Deruo
    Hu, Jian
    Wang, Luming
    CLINICAL LUNG CANCER, 2024, 25 (03) : e153 - e160